Kidney Cancer Market on the Rise: New Treatments and Technologies

Global kidney cancer diagnosis and treatment market is anticipated to grow at a substantial CAGR of 5.5% during the forecast period (2024-2031). The prevalence of kidney cancer will lead to an increase in the demand for effective treatment options, thus, driving the growth market. The new technological advancements in rapid diagnostics tools in the treatment of kidney cancer will rapidly increase the market. The growing demand for integrated Artificial Intelligence (AI) and Machine Learning (ML) in healthcare among others is propelling the market growth. The higher healthcare spending translates into an increasing demand for kidney cancer drugs contributing towards market growth. Additionally, the rising incidence of kidney cancer and, the demand for effective treatments, driving significant growth and competition among market players.

Browse the full report description of “Kidney Cancer Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Cancer Type (Renal Cell Carcinoma (RCC), Transitional Cell Cancer, and Wilm’s Tumour), by Cancer Cell (Clear Cell, Papillary, and Others), by Diagnosis Method (Biopsy, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), and Ultrasound), and by Therapy (Surgery, Immunotherapy, Chemotherapy, Radiation Therapy, and Cryotherapy) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/kidney-cancer-market

Recent Advancements in the Global Kidney Cancer Diagnosis and Treatment Market

• In January 2024, Gilead and Arcus Biosciences expanded the oncology partnership deal. The investment from Gilead in Arcus is aimed at expediting the growth of co-development programs for cancer indications. Gilead will invest $320.0 million in Arcus common stock to expedite the growth of co-development programs. The joint development program concentrates on Phase III studies.

• In September 2023, Merck announced that it has received priority review from the FDA for its supplemental new drug application (sNDA) for WELIREG, an oral inhibitor of hypoxia-inducible factor-2 alpha (HIF-2?), for the treatment of adult patients with advanced Renal Cell Carcinoma (RCC) after immune checkpoint and anti-angiogenic therapies.

• In September 2022, the Department of Defense's kidney cancer research program sanctioned $1.0 million as a grant for three years to Weill Cornell Medicine to help the research on the role of protein ATF4 in clear cell RCC.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered-

o By Cancer Type

o By Cancer Cell

o By Diagnosis

o By Therapy

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Bristol Myers Squibb, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Pfizer Inc., and Novartis AG, among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Kidney Cancer Diagnosis and Treatment Market Report Segment

By Cancer Type

• Renal Cell Carcinoma (RCC)
• Transitional Cell Cancer (TCC)
• Wilm’s Tumour (Nephroblastoma)
• Others (Sarcoma, Lymphoma)

By Cancer Cell

• Clear Cell
• Papillary 
• Others

By Diagnosis

• Biopsy
• Computed Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)
• Ultrasound

By Therapy

• Surgery
• Immunotherapy
• Chemotherapy
• Radiation Therapy
• Cryotherapy

Global Kidney Cancer Diagnosis and Treatment Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/kidney-cancer-market